Stock CLBT CELLEBRITE DI LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
10.88 USD +1.59% Intraday chart for Cellebrite DI Ltd. +3.92% +25.64%
04-19 Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target MT
04-01 BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company's profit outlook over the next few years is a strong asset.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 68.32 times its estimated earnings per share for the ongoing year.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company appears highly valued given the size of its balance sheet.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
CELLEBRITE DI LTD. Stock Cellebrite DI Ltd.
+25.64% 2.23B -
MICROSOFT CORPORATION Stock Microsoft Corporation
+8.05% 3,020B
C+
SYNOPSYS INC. Stock Synopsys Inc.
+5.58% 82.93B
B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+3.69% 76.85B
B+
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-14.62% 53.04B
B+
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+31.16% 50.15B
D+
ATLASSIAN CORPORATION Stock Atlassian Corporation
-24.56% 46.71B
B-
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+17.75% 41.41B
D+
SEA LIMITED Stock Sea Limited
+55.21% 36.1B
D+
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-10.24% 24.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLBT Stock
  4. Ratings Cellebrite DI Ltd.